Helicobacter Pylori infection increases the risk of colorectal adenomas: Cross-sectional study and meta-analysis

Digestive Diseases and Sciences

Volumn 57, Issue 8, 2012, Pages 2184-2194

  Hong, Sung Noh ^a,b   Lee, Seung Min ^a   Kim, Jeong Han ^a   Lee, Tae Yoon ^a   Kim, Jeong Hwan ^a   Choe, Won Hyeok ^a   Lee, Sun Young ^a   Cheon, Young Koog ^a   Sung, In Kyung ^a   Park, Hyung Seok ^a   Shim, Chan Sup ^a,b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Colorectal neoplasms; Cross sectional analysis; Helicobacter pylori; Meta analysis

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; COLYTE; COLYTE4L; HELIFINDER; UNCLASSIFIED DRUG; UREA C 13;

ALCOHOL CONSUMPTION; ARTICLE; BREATH ANALYSIS; CIGARETTE SMOKING; COLONOSCOPE; COLONOSCOPY; COLORECTAL ADENOMA; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUIPMENT; FAMILY HISTORY; GOLD STANDARD; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LABORATORY TEST; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING TEST; SEROLOGY; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ADENOMA; ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPUBLIC OF KOREA; SEROLOGIC TESTS;

EID: 84866383913     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2245-x     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658-662.
3. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med. 1993;329:1977-1981.
4. Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2011;12:504-512.
5. Jones M, Helliwell P, Pritchard C, et al. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol. 2007;5:51.
6. Grahn N, Hmani-Aifa M, Fransen K, et al. Molecular identification of helicobacter DNA present in human colorectal adenocarcinomas by 16s rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol. 2005;54:1031-1035.
7. Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001;96:3406-3410.
8. Hartwich A, Konturek SJ, Pierzchalski P, et al. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis. 2001;16:202-210.
9. Konturek SJ, Konturek PC, Hartwich A, et al. Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies. Regul Pept. 2000;93:13-19.
10. Marotta F, Hayakawa K, Mikami Y, et al. Relationship between gastrin cell number, serum, antral mucosa and luminal gastrin concentration and gastric acidity in antral atrophic gastritis. Gut. 1990;31:279-281.
11. Niv Y. Gastrin and colorectal neoplasia: cause and effect. Digestion. 2006;74:40-41.
12. Zhao YS, Wang F, Chang D, et al. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis. 2008;23:875-882.
13. Zumkeller N, Brenner H, Zwahlen M, et al. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter. 2006;11:75-80.
14. Abbass K, Gul W, Beck G, et al. Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma. South Med J. 2011;104:473-476.
15. Aydin A, Karasu Z, Zeytinoglu A, et al. Colorectal adenomateous polyps and Helicobacter pylori infection. Am J Gastroenterol. 1999;94:1121-1122.
16. Bae RC, Jeon SW, Cho HJ, et al. Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol. 2009;15:5722-5726.
17. Breuer-Katschinski B, Nemes K, Marr A, et al. Helicobacter pylori and the risk of colonic adenomas. Colorectal adenoma study group. Digestion. 1999;60:210-215.
18. Fujimori S, Kishida T, Kobayashi T, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol. 2005;40: 887-893.
19. Lin YL, Chiang JK, Lin SM, et al. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol. 2010;16:3841-3846.
20. Mizuno S, Morita Y, Inui T, et al. Helicobacter pylori infection is associated with colon adenomatous polyps detected by highresolution colonoscopy. Int J Cancer. 2005;117:1058-1059.
21. Moss SF, Neugut AI, Garbowski GC, et al. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995;87:762-763.
22. Siddheshwar RK, Muhammad KB, Gray JC, et al. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001;96:84-88.
23. Inoue I, Mukoubayashi C, Yoshimura N, et al. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer. 2011;129:2704-2711.
24. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-2752.
25. Kim HY, Kim N, Kang JM, et al. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea. Eur J Gastroenterol Hepatol. 2009;21: 606-612.
26. Bosman FT, Carneiro F, Hruban RH. WHO Classification of Tumours of the Digestive System, 4th ed. Lyon: WHO Press; 2010.
27. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter. 2007;12:1-3.
28. Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol. 1999;94:S11-S16.
29. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 2008;47:1077-1083.
30. Takeda H, Asaka M. Helicobacter pylori and colorectal neoplasm: a mysterious link? J Gastroenterol. 2005;40:919-920.
31. Robertson DJ, Sandler RS, Ahnen DJ, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009;7:163-167.
32. Argent RH, Hale JL, El-Omar EM, et al. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol. 2008;57:1062-1067.
33. Correa P, Miller MJ. Helicobacter pylori and gastric atrophycancer paradoxes. J Natl Cancer Inst. 1995;87:1731-1732.
34. Thorburn CM, Friedman GD, Dickinson CJ, et al. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 1998; 115:275-280.
35. Smith AM, Watson SA. Review article: gastrin and colorectal cancer. Aliment Pharmacol Ther. 2000;14:1231-1247.
36. Colucci R, Blandizzi C, Tanini M, et al. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase- 2 induction and prostaglandin E2 production. Br J Pharmacol. 2005;144:338-348.
37. McNulty CA, Lehours P, Megraud F. Diagnosis of Helicobacter pylori infection. Helicobacter. 2011;16:10-18.
38. Obata Y, Kikuchi S, Miwa H, et al. Diagnostic accuracy of serological kits for Helicobacter pylori infection with the same assay system but different antigens in a Japanese patient population. J Med Microbiol. 2003;52:889-892.